ILLUMINATE-C, a Single-arm, Phase 3 Study of Lumasiran in Patients with Primary Hyperoxaluria Type 1 and CKD3b-5, Including Those on Hemodialysis

ILLUMINATE-C, a Single-arm, Phase 3 Study of Lumasiran in Patients with Primary Hyperoxaluria Type 1 and CKD3b-5, Including Those on Hemodialysis

May 23, 2022
Collection: 2022 Posters
Credits: None available.
Type: Session
Speakers:
Tags: lumasiran oxalate Primary hyperoxaluria type 1 PH1lumasiran plasma oxalate cl impaired kidney function plasma clinical trial